Dr. med. Gerald Wulf

Name Card

Main Affiliation
 
Staff Status
unigoe
 

1-9 of 9
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2020 | Journal Article
    ​ ​Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1 -mutated AML: results from the AMLSG 09-09 trial​
    Kapp-Schwoerer, S.; Weber, D.; Corbacioglu, A.; Gaidzik, V. I.; Paschka, P.; Krönke, J. & Theis, F. et al.​ (2020) 
    Blood, 136(26) pp. 3041​-3050​.​ DOI: https://doi.org/10.1182/blood.2020005998 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Gemtuzumab Ozogamicin in NPM1 -Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study​
    Schlenk, R. F.; Paschka, P.; Krzykalla, J.; Weber, D.; Kapp-Schwoerer, S.; Gaidzik, V. I. & Leis, C. et al.​ (2020) 
    Journal of Clinical Oncology, 38(6) pp. 623​-632​.​ DOI: https://doi.org/10.1200/JCO.19.01406 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD​
    Schlenk, R. F.; Weber, D.; Fiedler, W.; Salih, H. R.; Wulf, G. ; Salwender, H. & Schroeder, T. et al.​ (2019) 
    Blood, 133(8) pp. 840​-851​.​ DOI: https://doi.org/10.1182/blood-2018-08-869453 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial​
    Paschka, P.; Schlenk, R. F; Weber, D.; Benner, A.; Bullinger, L.; Heuser, M. & Gaidzik, V. I et al.​ (2018) 
    Leukemia, 32(7) pp. 1621​-1630​.​ DOI: https://doi.org/10.1038/s41375-018-0129-6 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia (AML): Results from the Prospective Randomized AMLSG 09-09 Phase-III Study​
    Schlenk, R. F.; Paschka, P.; Krzykalla, J.; Weber, D.; Kapp-Schwoerer, S.; Gaidzik, V. I. & Leis, C. et al.​ (2018) 
    Blood, 132(Supplement 1) pp. 81​-81​.​ DOI: https://doi.org/10.1182/blood-2018-99-113442 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Monitoring of FLT3 Phosphorylation and FLT3 Ligand Levels in Patients with FLT3-ITD Mutated Acute Myeloid Leukemia (AML) Treated with Midostaurin within the AMLSG 16-10 Trial of the German-Austrian Study Group​
    Theis, F.; Weber, D.; Rücker, F. G.; Paschka, P.; Gaidzik, V. I.; Thol, F. & Heuser, M. et al.​ (2018) 
    Blood, 132(Supplement 1) pp. 1501​-1501​.​ DOI: https://doi.org/10.1182/blood-2018-99-114588 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Assessment of Treatment Effects By Measurable Residual Disease Monitoring in NPM1-Mutated AML Patients Randomized for Gemtuzumab-Ozogamicin (GO) within the AMLSG 09-09 Trial of the German-Austrian AML Study Group (AMLSG)​
    Kapp-Schwoerer, S.; Weber, D.; Corbacioglu, A.; Gaidzik, V. I.; Paschka, P.; Krönke, J. & Teleanu, M.-V. et al.​ (2018) 
    Blood, 132(Supplement 1) pp. 991​-991​.​ DOI: https://doi.org/10.1182/blood-2018-99-114648 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)​
    Nagel, G.; Weber, D.; Fromm, E.; Erhardt, S.; Lübbert, M.; Fiedler, W. & Kindler, T. et al.​ (2017) 
    Annals of Hematology, 96(12) pp. 1993​-2003​.​ DOI: https://doi.org/10.1007/s00277-017-3150-3 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Impact of Age and Midostaurin-Dose on Response and Outcome in Acute Myeloid Leukemia with FLT3-ITD: Interim-Analyses of the AMLSG 16-10 Trial​
    Schlenk, R. F.; Fiedler, W.; Salih, H. R.; Wulf, G. ; Thol, F.; Kündgen, A. & Kindler, T. et al.​ (2016) 
    Blood, 128(22) pp. 449​-449​.​ DOI: https://doi.org/10.1182/blood.V128.22.449.449 
    ​Details  DOI 

Publication List

All Articles (Book & Journal) Articles & Preprints Papers (Journal & Conference)

Filter

Active filter:
Contributor:  Döhner, Hartmut

Type

Date issued

Author

Language

Fulltext

Options

Citation Style

GRO View APA Chicago MLA Vancouver
https://publications.goettingen-research-online.de URI: /cris/rp/rp34512
ID: 0000000
PREF: default TOKEN:

0

Sort

Issue Date
ASC DESC
Title
ASC DESC

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.